BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 30, 2018
View Archived Issues
MicroRNA-31-5p levels defines disease course and clinical outcome in Crohn's disease
Read More
Inhibition of hippocampal TLR2 signaling prevents Alzheimer's disease development
Read More
Dual GLP-1/GIP agonist LY-3298176 superior to GLP-1 agonist dulaglutide for diabetes control
Read More
NEO-PV-01 induces broad and durable immune responses in patients with metastatic cancers
Read More
GC-1118 shows promising efficacy in patients with CRC resistant to prior EGFR antibody therapy
Read More
Activating toxin early mitigates C. difficile infection
Read More
Forcing mutated cells to grow up
Read More
New ROCK2 inhibitor REDX-10178 shows promise for the treatment of kidney injury
Read More
FDA approves Xyrem for cataplexy or excessive daytime sleepiness in pediatric narcolepsy patients
Read More
FDA approves Bijuva for moderate to severe hot flashes due to menopause
Read More
Xtandi granted approval in Europe for high-risk nonmetastatic castration-resistant prostate cancer
Read More
Promising topline phase III data presented for Baxdela for treatment of CABP
Read More
NEC and Transgene sign MOU for cancer immunotherapy collaboration
Read More
Spark Therapeutics presents post-hoc analyses of phase III Luxturna data
Read More
Clearside Biomedical presents additional phase III data for Xipere in uveitic macular edema
Read More
Phase III study of daratumumab in front-line multiple myeloma meets primary endpoint
Read More
FDA allows IND for Athenex's oral eribulin
Read More
TMPRSS11E gene identified as a novel biomarker of smoking-related traits in Europeans
Read More
CS-1001 demonstrates promising preliminary safety and antitumor activity in phase I study
Read More
Preliminary data presented from phase I/II study of AGEN-1884 in combination with AGEN-2034
Read More
hNIS transgenic mouse as a resource of stem cells innately enabling in vivo cell tracking
Read More
CTAD 2018: Change in target? Maybe. Change in culture? Yes
Read More